Natural Product: NPC586201

Natural Product IDNPC586201
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(8~{S},9~{S},10~{R},13~{R},14~{S},17~{R})-17-[(~{Z},1~{R})-4-isopropyl-1-methyl-hex-4-enyl]-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
IUPAC Name (8~{S},9~{S},10~{R},13~{R},14~{S},17~{R})-17-[(~{Z},1~{R})-4-isopropyl-1-methyl-hex-4-enyl]-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VGJTXGHBABVZAB-SHONWSSPSA-N
Standard InCHI InChI=1S/C29H44O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h7,14,16,18-20,24-27H,8-13,15,17H2,1-6H3/b21-7-/t20-,24+,25-,26+,27+,28+,29-/m1/s1
SMILES C/C=C(/CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C)C(C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   408.34 Volume:   474.159
?
Van der Waals volume.
Dense:   0.861 LogP:   6.878
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.695
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -6.924
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   22.0
TPSA:   17.07
?
Topological Polar Surface Area.
H-Bond Acceptor:   1.0
H-Bond Donor:   0.0 Rings:   4.0
Heavy Atoms:   1.0

MedChem Properties

QED Drug-Likeness Score:   0.422 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.484 Fsp3:   0.759
MCE-18:   66.706
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.959 Fluc inhibitor:   0.276
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.023
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.652 Promiscuous compounds:   0.133

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.962 MDCK Permeability:   -4.88
Pgp-inhibitor:   0.791 Pgp-substrate:   0.0
PAMPA:   0.002
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.018 30% Bioavailability (F30%):   0.329
50% Bioavailability (F50%):   0.944

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.31 MRP1:   0.02
Plasma Protein Binding (PPB):   97.347% Volume Distribution (VD):   0.407
Fu: 2.995%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.177
BSEP inhibitor:   0.969

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.064
CYP2C19-inhibitor:   0.447 CYP2C19-substrate:   0.005
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.01
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.995
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.547
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  11.192 Half-life (T1/2):  0.211

ADMET: Toxicity

hERG Blockers:  0.135 hERG Blockers (10um):  0.605
Human Hepatotoxicity (H-HT):  0.842 Drug-induced Liver Injury (DILI):  0.336
AMES Toxicity:  0.232 Rat Oral Acute Toxicity:  0.297
Maximum Recommended Daily Dose:  0.733 Skin Sensitization:  0.989
Carcinogencity:  0.896 Eye Corrosion:  0.466
Eye Irritation:  0.996 Respiratory Toxicity:  0.984
Drug-induced Neurotoxicity:  0.141 Ototoxicity:  0.194
Hematotoxicity:  0.153 Drug-induced Nephrotoxicity:  0.301
Genotoxicity:  0.664 RPMI-8226 Immunitoxicity:  0.061
A549 Cytotoxicity:  0.035 Hek293 Cytotoxicity:  0.648
BCF:   3.201
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.123
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.718
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.936
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO49555 Muricella sibogae Genus Anthogorgiidae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC586201 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7872 Intermediate Similarity NPC92327
0.7143 Intermediate Similarity NPC190211
0.6981 Remote Similarity NPC176107
0.6852 Remote Similarity NPC105197
0.6607 Remote Similarity NPC474463
0.6441 Remote Similarity NPC608739
0.6415 Remote Similarity NPC282593
0.6271 Remote Similarity NPC218301
0.6271 Remote Similarity NPC273199
0.6066 Remote Similarity NPC255309
0.6038 Remote Similarity NPC54123
0.5781 Remote Similarity NPC177141
0.5714 Remote Similarity NPC159577
0.5714 Remote Similarity NPC6434
0.5385 Remote Similarity NPC164835
0.5385 Remote Similarity NPC228669
0.5312 Remote Similarity NPC29447
0.5312 Remote Similarity NPC470923
0.5254 Remote Similarity NPC303613
0.5231 Remote Similarity NPC310981
0.5172 Remote Similarity NPC35734
0.5172 Remote Similarity NPC30421
0.5172 Remote Similarity NPC602429
0.5147 Remote Similarity NPC58052
0.5147 Remote Similarity NPC600537
0.5085 Remote Similarity NPC149203
0.5075 Remote Similarity NPC128488
0.5075 Remote Similarity NPC304968
0.5072 Remote Similarity NPC601481

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC586201 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5714 Remote Similarity NPD4195 Phase 4
0.5172 Remote Similarity NPD3573 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data